tiprankstipranks
Cognition Therapeutics (CGTX)
NASDAQ:CGTX
US Market
CGTX
Cognition Therapeutics
RESEARCH TOOLSreports

Cognition Therapeutics (CGTX) Income Statement

618 Followers

Cognition Therapeutics Income Statement

Last quarter (Q4 2025), Cognition Therapeutics's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q4, Cognition Therapeutics's net income was $-3.34M. See Cognition Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ -228.00K$ 0.00$ -252.00K$ -235.00K$ 0.00
Operating Expenses
$ 47.80M$ 53.97M$ 50.72M$ 43.32M$ 28.60M
Depreciation and Amortization
$ 228.00K$ 266.00K$ 252.00K$ 235.00K$ 93.00K
EBITDA
$ -47.80M$ -33.68M$ -25.51M$ -21.13M$ -10.73M
Operating Income
$ -47.80M$ -53.97M$ -50.72M$ -43.55M$ -28.60M
Other Income/Expenses
$ 24.31M$ 20.00M$ 24.94M$ 22.15M$ 16.88M
Pretax Income
$ -23.49M$ -33.97M$ -25.79M$ -21.40M$ -11.72M
Net Income
$ -23.49M$ -33.97M$ -25.79M$ 757.00K$ -11.72M
Per Share Metrics
Basic EPS
$ -0.32$ -0.85$ -0.86$ -0.74$ -0.73
Diluted EPS
$ -0.32$ -0.85$ -0.86$ -0.74$ -0.73
Weighted Average Shares Outstanding
 72.77M 39.73M 29.99M 28.99M 22.23M
Weighted Average Shares Outstanding (Diluted)
 72.77M 39.73M 30.03M 28.99M 22.23M
Currency in USD

Cognition Therapeutics Earnings and Revenue History